Carol H. Wasilauskas

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

Valery T. Miller, John C. LaRosa, Vanessa M. Barnabei et al. · JAMA · 1995 · 605 citations

Medicine, Endocrinology, Pharmacology +15

Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal Density

Gail A. Greendale, Beth A. Reboussin, Angela Sie et al. · Annals of Internal Medicine · 1999 · 407 citations

Medicine, Endocrinology, Oncology +17

Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration

Mark A. Espeland, Santica M. Marcovina, Valery T. Miller et al. · Circulation · 1998 · 186 citations

Pharmacy, Endocrinology, Reproductive Endocrinology +15

The Relationship of Biochemical Markers of Bone Turnover to Bone Density Changes in Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

Robert Marcus, Leah Holloway, Bradley Wells et al. · Journal of Bone and Mineral Research · 1999 · 117 citations

Medicine, Endocrinology, Bone Metabolism +16

Post-Treatment Change in Serum Estrone Predicts Mammographic Percent Density Changes in Women Who Received Combination Estrogen and Progestin in the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

Giske Ursin, Shana L. Palla, Beth A. Reboussin et al. · Journal of Clinical Oncology · 2004 · 30 citations · Full text

Medicine, Endocrinology, Gynecology +17